AKT1 and cancer: The inhibitory effect of anthocyanins on the PI3K/AKT/Mcl-1 axis highlights their potential as therapeutic agents in diseases characterized by excessive cell survival and resistance to apoptosis, such as cancer and chronic inflammatory conditions (67).